Close

Ratings by Piper Sandler (Yasmeen Rahimi)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/16/2024 AnaptysBio ANAB New Coverage Overweight
(N/A)
22.29
(25.87)
16.06% Details
2/13/2024 CymaBay Therapeutic CBAY Downgrade Neutral
(Overweight)
32.21
(32.23)
0.06% Details
2/5/2024 Soleno Therapeutics Inc. SLNO New Coverage Overweight
(N/A)
46.92
(49.00)
4.43% Details
1/16/2024 NewAmsterdam Pharma Co NV NAMS New Coverage Overweight
(N/A)
17.11
(23.14)
35.24% Details
12/18/2023 Structure Therapeutics GPCR Maintain Overweight
(N/A)
 
 
  Details
12/14/2023 Reneo Pharmaceuticals RPHM Downgrade Neutral
(Overweight)
7.75
(1.61)
-79.23% Details
11/14/2023 Design Therapeutics Inc DSGN Downgrade Neutral
(Overweight)
2.05
(2.80)
36.59% Details
11/10/2023 Korro Bio Inc. KRRO New Coverage Overweight
(N/A)
41.40
(49.99)
20.75% Details
11/6/2023 CymaBay Therapeutic CBAY Maintain Overweight
(N/A)
 
 
  Details
10/26/2023 Structure Therapeutics GPCR Maintain Overweight
(N/A)
 
 
  Details
10/25/2023 Tourmaline Bio TRML New Coverage Overweight
(N/A)
9.46
(36.67)
287.63% Details
10/24/2023 Immunovant IMVT Maintain Overweight
(N/A)
 
 
  Details
8/8/2023 Sagimet Biosciences Inc SGMT New Coverage Overweight
(N/A)
16.09
(6.62)
-58.86% Details
7/27/2023 Structure Therapeutics GPCR New Coverage Overweight
(N/A)
35.14
(40.51)
15.28% Details
5/30/2023 Acelyrin Inc SLRN New Coverage Overweight
(N/A)
19.42
(7.41)
-61.84% Details
4/24/2023 Crinetics CRNX New Coverage Overweight
(N/A)
17.22
(36.85)
114% Details
4/18/2023 Prometheus Biosciences Inc RXDX Downgrade Neutral
(Overweight)
114.01
(199.92)
75.35% Details
3/31/2023 Immunovant IMVT New Coverage Overweight
(N/A)
15.71
(37.00)
135.52% Details
3/7/2023 Allakos Inc. ALLK New Coverage Overweight
(N/A)
5.80
(1.36)
-76.55% Details
3/6/2023 Chinook Therapeutics KDNY New Coverage Overweight
(N/A)
22.81
(40.39)
77.07% Details
2/22/2023 Cincor Pharma Inc CINC Maintain Overweight
(N/A)
 
 
  Details
1/27/2023 Prothena Corp PRTA New Coverage Overweight
(N/A)
55.25
(27.22)
-50.73% Details
12/19/2022 Madrigal Pharmaceuticals MDGL Maintain Overweight
(N/A)
 
 
  Details
9/12/2022 Ventyx Biosciences Inc VTYX Maintain Overweight
(N/A)
 
 
  Details
8/29/2022 Prometheus Biosciences Inc RXDX Maintain Overweight
(N/A)
 
 
  Details
8/26/2022 Verona Pharma VRNA New Coverage Overweight
(N/A)
10.59
(16.49)
55.71% Details
8/22/2022 Cincor Pharma Inc CINC New Coverage Overweight
(N/A)
35.02
(29.06)
-17.02% Details
8/19/2022 Ventyx Biosciences Inc VTYX Maintain Overweight
(N/A)
 
 
  Details
8/12/2022 Lexicon Pharmaceuticals LXRX New Coverage Overweight
(N/A)
2.78
(2.54)
-8.63% Details
6/10/2022 Cytokinetics CYTK Maintain Overweight
(N/A)
 
 
  Details
6/10/2022 Prometheus Biosciences Inc RXDX New Coverage Overweight
(N/A)
29.00
(199.92)
589.38% Details
6/7/2022 Intercept Pharmaceuticals ICPT Maintain Overweight
(N/A)
 
 
  Details
5/6/2022 Protagonist Therapeutics PTGX Maintain Overweight
(N/A)
 
 
  Details
3/29/2022 Ventyx Biosciences Inc VTYX Maintain Overweight
(N/A)
 
 
  Details
3/22/2022 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
11/15/2021 Ventyx Biosciences Inc VTYX New Coverage Overweight
(N/A)
22.97
(6.71)
-70.79% Details
10/12/2021 Protagonist Therapeutics PTGX Maintain Overweight
(N/A)
 
 
  Details
10/5/2021 Cytokinetics CYTK Maintain Overweight
(N/A)
 
 
  Details
9/22/2021 Mirum Pharamceuticals MIRM Maintain Overweight
(N/A)
 
 
  Details
9/21/2021 Gossamer Bio Inc. GOSS New Coverage Overweight
(N/A)
10.52
(1.30)
-87.64% Details
9/8/2021 Altimmune ALT Maintain Overweight
(N/A)
 
 
  Details
8/24/2021 Tenaya Therapeutics Inc TNYA New Coverage Overweight
(N/A)
22.67
(5.22)
-76.97% Details
8/6/2021 NGM Biopharmaceuticals NGM Maintain Overweight
(N/A)
 
 
  Details
7/30/2021 Protagonist Therapeutics PTGX Maintain Overweight
(N/A)
 
 
  Details
6/11/2021 Vaxart Inc. VXRT New Coverage Overweight
(N/A)
7.64
(1.27)
-83.38% Details
6/9/2021 Intercept Pharmaceuticals ICPT Maintain Overweight
(N/A)
 
 
  Details
6/2/2021 Liminal BioSciences, Inc. LMNL Downgrade Neutral
(Overweight)
4.42
(8.50)
92.31% Details
5/21/2021 Protagonist Therapeutics PTGX Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Madrigal Pharmaceuticals MDGL Maintain Overweight
(N/A)
 
 
  Details
5/4/2021 Reneo Pharmaceuticals RPHM New Coverage Overweight
(N/A)
14.40
(1.61)
-88.82% Details
4/20/2021 Design Therapeutics Inc DSGN New Coverage Overweight
(N/A)
23.50
(2.80)
-88.09% Details
4/7/2021 Sage Therapeutics SAGE New Coverage Overweight
(N/A)
77.89
(22.01)
-71.74% Details
3/16/2021 Savara SVRA New Coverage Overweight
(N/A)
1.57
(5.12)
226.11% Details
3/9/2021 CymaBay Therapeutic CBAY Maintain Overweight
(N/A)
 
 
  Details
3/1/2021 Albireo Pharma ALBO Maintain Overweight
(N/A)
 
 
  Details
12/21/2020 Liminal BioSciences, Inc. LMNL New Coverage Overweight
(N/A)
4.09
(8.50)
107.82% Details
12/16/2020 Protagonist Therapeutics PTGX New Coverage Overweight
(N/A)
20.92
(28.48)
36.14% Details
9/28/2020 Mirum Pharamceuticals MIRM Maintain Overweight
(N/A)
 
 
  Details
9/8/2020 Albireo Pharma ALBO Maintain Overweight
(N/A)
 
 
  Details
9/4/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/26/2020 Arcturus Therapeutics ARCT New Coverage Overweight
(N/A)
54.24
(37.42)
-31.01% Details
8/26/2020 Enanta Pharmaceuticals ENTA New Coverage Overweight
(N/A)
49.02
(13.46)
-72.54% Details
8/26/2020 Immunic Inc. IMUX New Coverage Overweight
(N/A)
15.29
(1.22)
-92.02% Details
8/26/2020 Lumos Pharma LUMO New Coverage Overweight
(N/A)
14.96
(3.00)
-79.95% Details
8/25/2020 Amarin Corporation AMRN New Coverage Overweight
(N/A)
6.79
(1.19)
-82.47% Details
7/31/2020 89bio Inc. ETNB New Coverage Overweight
(N/A)
28.77
(11.18)
-61.14% Details
7/31/2020 Mirum Pharamceuticals MIRM New Coverage Overweight
(N/A)
20.26
(27.81)
37.27% Details
7/31/2020 89bio Inc. ETNB New Coverage Overweight
(N/A)
28.77
(11.18)
-61.14% Details
7/31/2020 CymaBay Therapeutic CBAY New Coverage Overweight
(N/A)
3.53
(32.23)
813.03% Details
7/31/2020 Axcella Health Inc. AXLA New Coverage Overweight
(N/A)
4.51
(4.58)
1.55% Details
7/31/2020 Albireo Pharma ALBO New Coverage Overweight
(N/A)
25.55
(44.15)
72.8% Details
7/31/2020 NGM Biopharmaceuticals NGM New Coverage Overweight
(N/A)
18.43
(1.91)
-89.64% Details
7/31/2020 Altimmune ALT New Coverage Overweight
(N/A)
22.52
(9.20)
-59.15% Details
7/31/2020 Madrigal Pharmaceuticals MDGL New Coverage Overweight
(N/A)
103.30
(236.54)
128.98% Details
7/31/2020 Intercept Pharmaceuticals ICPT New Coverage Overweight
(N/A)
45.60
(19.00)
-58.33% Details